Total Results: 489

Under Pressure To Reduce Red Tape, FDA To Hold Hearing On Approval Process

KHN Morning Briefing

The Food and Drug Administration implemented a more structured approach to how new drugs are approved based on their safety risks as part of the reauthorization of the Prescription Drug User Fee Act in 2010. At the meeting, the agency will likely hear testimony on experiences with this approach.

To Circumvent Patent Challenges, This Pharma Company Made A Deal With A Native American Tribe

KHN Morning Briefing

Now that the deal has been made public, other drugmakers are taking interest. In other pharmaceutical news, the struggle to create a Zika vaccine highlights a broader public health problem, the Food and Drug Administration is changing the way it approves orphan drugs, the House has begun work on a bill that would boost the agency’s oversight of over-the-counter drugs, and more.

Lawmakers Enthusiastically Reject Trump’s Proposal To Cut NIH Funding

KHN Morning Briefing

The Senate Appropriations Committee approved a bipartisan bill last week providing $36.1 billion for the health institutes. Senator Roy Blunt (R-Mo.) said it was the third consecutive year in which he had secured a $2 billion increase for the agency, and, in a separate hearing the audience erupted in applause when Senator Lamar Alexander, Republican of Tennessee, announced the boost in funding.